Retraction notice to “Synthesis, molecular docking study and anticancer activity of novel 1,3,4-oxadiazole derivatives as potential tubulin inhibitors” [Heliyon 9 (2023) e13460](S2405844023006679)(10.1016/j.heliyon.2023.e13460)

초록

This article has been retracted: please see Elsevier policy on article withdrawal (https://www.elsevier.com/about/policies-and-standards/article-withdrawal). This article has been retracted at the request of the Editor. Post-publication, an investigation conducted on behalf of the journal by Elsevier's Research Integrity & Publishing Ethics team discovered substantial changes in authorship during the submission process of this paper. During revision, Abdulrahman Alhamzani, G. Kanthimathi, Mortaga Abou-Krisha, and Tarek Yousef were added to the author list, and 3 authors were removed, without adequate explanation. The Editor does not have confidence that all of the stated authors of the article qualify for authorship and has therefore lost confidence in the validity/integrity of the article and made the decision to retract. The authors disagree with retraction and dispute the grounds for it.